A Reimers
Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation
Emmenegger U, Spaeth P, Cerny A, Cottagnoud P, Semela D, Bihl F, Fux C, Frey U, Reimers A, Neftel K. Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly 2002; 132:230-6.
04.05.2002Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation
04.05.2002Swiss Med Wkly 2002; 132:230-6
Emmenegger U, Spaeth P J, Cerny A, Cottagnoud P, Semela David, Bihl F, Fux Ch, Frey U, Reimers A, Neftel Klaus A
Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes
Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P, Spaeth P, Neftel K. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 2001; 68:4-10.
01.09.2001Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes
01.09.2001Am J Hematol 2001; 68:4-10
Emmenegger U, Frey U, Reimers A, Fux C, Semela David, Cottagnoud P, Spaeth P J, Neftel K A